Even though Eomeslo ILC1 group is phenotypically similar to that of conventional ILC1s, Eomeslo ILC1s produces lower cytotoxicity and IFN-γ levels compared with Eomeshi cells, suggesting that the low Eomes levels in ILC1s may be associated with decreased cancer immunosurveillance and early tumour suppression functions (Verma et al., 2020). The gene discussed is IFNG; the disease is cancer.